504A JPX Week ended 07 Aug 2026

Weekly Investor Report

Name: 504A weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

Innovacell Inc. · Healthcare · Biotechnology

Open interactive chart View report data

Latest close 527.0 JPY

-2.6% latest week

Weekly setup

Mixed setup

The weekly trend is not active. Price is - below the Trend Line and sits at 17.2% of its 52-week range. The latest completed week returned -2.6%, after a 7.1% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 29 out of 100

Latest Close 527.0 JPY 7 Aug 2026

1W Return -2.6% latest completed week

4W Return 7.1% short-term follow-through

12W Return -17.9% quarterly tape

Trend Breadth 0.0% 0 of 24 weeks active

Volume Ratio 0.7x vs 13-week average

What is working

No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.

What could go wrong

The trend backdrop is inactive, so price action has not confirmed a constructive regime.
Price is below Fair Value, so the market is still discounting the latest tape.
Activity pressure is negative, which weakens the current setup.
Next-week expectancy is negative at 31.34% based on similar historical setup states.

What to watch next

Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through -2.6% Latest completed week; four-week move 7.1%. Indicator stack 0/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 31.34% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 5 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is - below the Trend Line and sits at 17.2% of its 52-week range. The latest completed week returned -2.6%, after a 7.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

377.0 JPY 17.2% 1,248 JPY

Range location17.2%Shows where the latest close sits between the 52-week low and high.

Trend distance-Price premium or discount versus the weekly Trend Line.

Fair-value gap-20.6%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-57.8%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0212-week average 0.01

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.02Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.1% over four weeks, -17.9% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.6%

4W7.1%

12W-17.9%

26W-

52W-

Active trend streak0 weeks

Active weeks in one year0

Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure0.00Latest activity-pressure read.

Pressure change-Four-week change in activity pressure.

Leadership-Latest relative-leadership reading.

RS change-Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 5 relevant articles.

0 positive · 5 neutral · 0 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-57.8%Distance below the 52-week high.

13-week volatility15.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

27 Feb 27 Mar 24 Apr 22 May 19 Jun 17 Jul 7 Aug

Weeks higher7 of 2316 weeks finished lower.

Best week+41.0%Week of 3 Jul.

Worst week-20.3%Week of 29 May.

Latest week-2.6%Week of 7 Aug.

Shape of recent returns

Strong gains7

Modest gains0

Flat weeks0

Modest losses4

Sharp losses12

Recent vol15.9%13-week weekly-return volatility.

Base vol12.9%52-week weekly-return volatility.

Up/down split7/16Count of positive and negative weeks in the 52-week window.

Average skew13.5% / -8.5%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorJP Healthcare

4-week rank21 / 100

Group average1.5%

Trend breadth29.0%

Trend29.0%active weekly trend signals

MD56.0%positive activity pressure

RS13.0%positive relative leadership

Four-week leaders

7774 · JPX26.9%7780 · JPX25.4%6523 · JPX24.7%2395 · JPX15.3%4578 · JPX13.6%

IndustryJP Biotechnology

4-week rank4 / 47

Group average-1.7%

Trend breadth6.4%

Trend6.4%active weekly trend signals

MD25.5%positive activity pressure

RS4.3%positive relative leadership

Four-week leaders

7774 · JPX26.9%219A · JPX12.6%4588 · JPX10.6%504A · JPX7.1%2160 · JPX6.6%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape25/100

Trend, activity pressure, participation, and risk combine to a 25/100 tape read.

Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.02; No reversal markers Next-Week ExpectancyNegative 31.34%

Next-week expectancy is negative with a 31.34% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 5 relevant articles.

EVERSANA Selected by Innovacell as Commercialization Partner to Advance Novel Cell Therapy ICEF15 in the United States Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Leadership	Volume	Trend
7 Aug 2026	527.0 JPY	-2.6%	-	663.8 JPY	-	298.3K	Off
31 Jul 2026	541.0 JPY	15.6%	-	669.7 JPY	-	1.0M	Off
24 Jul 2026	468.0 JPY	-0.6%	-	675.5 JPY	-	486.9K	Off
17 Jul 2026	471.0 JPY	-4.3%	-	685.4 JPY	-	606.4K	Off
10 Jul 2026	492.0 JPY	-9.4%	-	696.1 JPY	-	1.4M	Off
3 Jul 2026	543.0 JPY	41.0%	-	706.9 JPY	-	12.9K	Off
26 Jun 2026	385.0 JPY	-18.3%	-	716.0 JPY	-	136.6K	Off
19 Jun 2026	471.0 JPY	-7.8%	-	735.5 JPY	-	93.2K	Off
12 Jun 2026	511.0 JPY	-16.2%	-	752.0 JPY	-	138.2K	Off
5 Jun 2026	610.0 JPY	7.8%	-	768.1 JPY	-	87.4K	Off
29 May 2026	566.0 JPY	-20.3%	-	779.4 JPY	-	589.0K	Off
22 May 2026	710.0 JPY	10.6%	-	795.8 JPY	-	358.0K	Off
15 May 2026	642.0 JPY	-1.2%	-	802.9 JPY	-	472.5K	Off
8 May 2026	650.0 JPY	7.4%	-	817.5 JPY	-	307.8K	Off

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.